10 Sikkerheden ved Rebetol kapsler er vurderet på basis af data fra tre kliniske undersøgelser hos patienter uden tidligere eksponering for interferon (interferon- naive patienter): to undersøgelser vurderede Rebetol i kombination med interferon alfa- 2b, en undersøgelse vurderede Rebetol i kombination med peginterferon alfa- 2b.
10 The safety of Rebetol capsules is evaluated from data from three clinical trials in patients with no previous exposure to interferon (interferon-naïve patients): two trials studied Rebetol in combination with interferon alfa-2b, one trial studied Rebetol in combination with peginterferon alfa-2b.